Clinical Significance of C Reactive Protein and Procalcitonin Detection in Neonatal ABO Hemolytic Jaundice
-
摘要:
目的 探讨检测C反应蛋白和降钙素原在新生儿ABO溶血性黄疸中的临床意义。 方法 选云南省某三甲医院2021年9月至2022年8月入院的ABO溶血性黄疸新生儿50例为观察组,同期的53例非溶血性病理性黄疸新生儿作为对照组,采用回顾性分析,对比分析2组患儿CRP、PCT水平、异常值检出率及感染发生率。 结果 观察组CRP水平[11.0000(9.1750,13.0025)]、PCT水平[0.6750(0.3175,2.9025)]、CRP异常值检出率(80%)、PCT异常值检出率(66%)、感染发生率(34%)均高于对照组CRP水平[1.5000(0.7000,7.5000)]、PCT水平[0.3200(0.2000,0.5850)]、CRP异常值检出率(41.5%)、PCT异常值检出率(32.1%)、感染发生率(11.3%),差异具有统计学意义(P<0.05);CRP诊断新生儿病情进展的ROC曲线下面积(AUC)为0.664,灵敏度为91.3%,特异度为46.2%;PCT的AUC为0.711,灵敏度为82.6%,特异度为60.0%。 结论 CRP、PCT在新生儿ABO溶血性黄疸中可见明显升高,对其检测可尽早发现新生儿的病情进展情况,确保临床及时采取有效的治疗护理措施,对促进新生儿的早期康复具有重要意义。 Abstract:Objective To investigate the clinical significance of c reactive protein and procalcitonin levels in neonatal ABO hemolytic jaundice . Methods A total of 50 ABO hemolytic jaundice neonates admitted to a grade III and class A hospital in Yunnan Province between September 2021and August 2022 were selected as the observation group and 53 newborns with non hemolytic and pathological jaundice were selected as the control group during the same period. Retrospective analysis was used to compare the levels of CRP and PCT, abnormal value detection rate and infection rate between the two groups. Results The levels of CRP [11.0000 (9.1750, 13.0025)], PCT [0.6750 (0.3175, 2.9025)], the detection rate of CRP abnormal value (80%), the detection rate of PCT abnormal value (66%) and the incidence of infection (34%) in the observation group were higher than those in the control group [1.5000 (0.7000, 7.5000), PCT level [0.3200 (0.2000, 0.5850)], CRP abnormal value detection rate (41.5%), PCT abnormal value detection rate (32.1%) and infection incidence rate (11.3%)]. The differences were statistically significant (P < 0.05). The area under the curve (AUC) of CRP in the diagnosis of neonatal progression was 0.664, the sensitivity was 91.3%, and the specificity was 46.2%. PCT had an AUC of 0.711, a sensitivity of 82.6%, and a specificity of 60.0%. Conclusion CRP and PCT can be significantly elevated in the early stage of neonatal ABO hemolytic jaundice, and its detection can detect the progress of the condition as early as possible, ensure the effectiveness of treatment and nursing measures taken in time in clinical practices, and have the great significance in promoting the early rehabilitation of newborns. -
Key words:
- ABO hemolytic jaundice /
- C reactive protein /
- Procalcitonin /
- Newborn
-
表 1 新生儿一般资料比较[n(%)/M(P25,P75)/
$\bar x \pm s $ ]Table 1. Comparison of general data of newborns [n(%)/M(P25,P75)/
$\bar x \pm s $ ]项目 观察组(n = 50) 对照组(n = 53) χ2/Z/t P 性别 0.220 0.639 男 26(52.0) 30(56.6) 女 24(48.0) 23(43.4) 胎龄(周) 38.00(38.00,39.00) 39.00(37.00,40.00) −0.538 0.591 入院日龄(d) 2.50(1.00,4.25) 4.00(2.00,5.00) −1.901 0.057 出生体质量(g) 3281.2 ± 430.796 3161.98 ± 521.124 1.261 0.210 出生方式 0.122 0.727 顺产 30(60.0) 30(56.6) 剖宫产 20(40.0) 23(43.4) 表 2 新生儿C反应蛋白和降钙素原水平比较[M(P25,P75)]
Table 2. Comparison of c reactive protein and procalcitonin levels in newborns [M(P25,P75)]
组别 C反应蛋白(mg/L) 降钙素原(ng/mL) 观察组(n = 50) 11.0000(9.1750,13.0025*) 0.6750(0.3175,2.9025*) 对照组(n = 53) 1.5000(0.7000,7.5000) 0.3200(0.2000,0.5850) Z −6.194 −3.318 P < 0.001* < 0.001* 与对照组比较,* P < 0.05。 表 3 新生儿CRP、PCT异常值检出率比较(%)
Table 3. Comparison of the detection rate of abnormal values of CRP and PCT in newborns (%)
组别 CRP PCT 异常检出例数(n) 异常值检出率 异常检出例数(n) 异常值检出率 观察组(n = 50) 40 80.0* 33 66.0* 对照组(n = 53) 22 41.5 17 32.1 χ2 31.694 11.854 P < 0.001* 0.001* 与对照组比较,* P < 0.05。 表 4 新生儿感染发生率比较(%)
Table 4. Comparison of the incidence of neonatal infection (%)
组别 感染例数(n) 感染发生率 观察组(n = 50) 17 34.0* 对照组(n = 53) 6 11.3 χ2 7.630 P 0.006 与对照组比较,*P < 0.05。 表 5 CRP、PCT的ROC曲线参数
Table 5. ROC curve parameters of CRP and PCT
指标 灵敏度(%) 特异度(%) 截断值 AUC 95%CI CRP 91.3 46.2 0.375 0.664 0.550 0.777 PCT 82.6 60.0 0.426 0.711 0.593 0.828 -
[1] 黄剑萍,叶晖勇. 胆红素、血红蛋白、肝酶、心肌酶在新生儿溶血性黄疸早期诊断中临床价值分析[J]. 医学理论与实践,2021,34(10):1756-1757. doi: 10.19381/j.issn.1001-7585.2021.10.063 [2] 邓婉,周玉娥,刘天云,等. 碳氧血红蛋白在新生儿ABO溶血性黄疸中的临床意义[J]. 昆明医科大学学报,2021,42(5):143-146. doi: 10.12259/j.issn.2095-610X.S20210526 [3] 陈为俊,王海燕,管洪在. 新生儿溶血病血清学检测及相关指标分析[J]. 心理医生,2019,25(4):93-94. [4] 吴随云,康淑琴. 针对性护理干预在新生儿ABO溶血性黄疸蓝光照射治疗中的效果分析[J]. 医学理论与实践,2022,35(10):1768-1770. doi: 10.19381/j.issn.1001-7585.2022.10.066 [5] 朱娟,徐乐,姜忠莉. 血清学指标联合预测新生儿ABO溶血性黄疸短期预后的价值[J]. 中华临床医师杂志(电子版),2021,15(6):433-438. doi: 10.3877/cma.j.issn.1674-0785.2021.06.006 [6] Mitra S,Rennie J. Neonatal jaundice: Aetiology,diagnosis and treatment[J]. Br J Hosp Med (Lond),2017,78(12):699-704. doi: 10.12968/hmed.2017.78.12.699 [7] Metcalf R A,Khan J,Andrews J,et al. Severe ABO hemolytic disease of the newborn requiring exchange transfusion[J]. Pediatr Hematol Oncol,2019,41(8):632-634. doi: 10.1097/MPH.0000000000001248 [8] 李新红,万忠和,苏惠文,等. 新生儿ABO溶血性黄疸CRP、PCT检测的临床意义[J]. 现代诊断与治疗,2020,31(14):2250-2252. [9] 邵肖梅, 叶鸿帽, 邱小汕. 实用新生儿学[M]. 第5版. 北京: 人民卫生出版社, 2019: 764-769. [10] 中华医学会儿科学分会新生儿学组,中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志,2019,57(4):252-257. doi: 10.3760/cma.j.issn.0578-1310.2019.04.005 [11] Christensen R D,Baer V L,MacQueen B C,et al. ABO hemolytic disease of the fetus and newborn: Thirteen years of data after implementing a universal bilirubin screening and management program.[J]. Perinatol,2018,38(5):517-525. doi: 10.1038/s41372-018-0048-4 [12] 高翠,王利春. 影响新生儿并发高胆红素血症的危险因素分析[J]. 现代医学与健康研究电子杂志,2022,6(11):124-127. [13] 邵民坤,周燕,杜坤,等. 炎性指标联合检测在鉴别诊断新生儿感染中的临床评价[J]. 中华医院感染学杂志,2016,26(7):1639-1641. [14] 邱华波. C反应蛋白和降钙素原在新生儿ABO溶血病中的临床应用[J]. 临床合理用药杂志,2016,9(31):162-163. [15] 裴夏南,钱新华,丁静. C反应蛋白和降钙素原在新生儿ABO溶血病中的临床意义[J]. 山西医科大学学报,2014,45(5):391-395. [16] 孙海潮,苗伶俐,屈伟. C反应蛋白和降钙素原在新生儿ABO溶血病中的临床意义[J]. 临床医学研究与实践,2018,3(3):107-108. [17] 沈洁,蒋亚君,吴艳,等. C反应蛋白和降钙素原在足月新生儿ABO溶血病中的临床应用[J]. 重庆医学,2020,49(18):3078-3083. doi: 10.3969/j.issn.1671-8348.2020.18.024 [18] 杨瑞兰,彭祖菊,贺雨,等. 1191例新生儿脐血感染生物学指标参考区间调查分析[J]. 重庆医学,2015,44(30):4258-4261. doi: 10.3969/j.issn.1671-8348.2015.30.027 [19] 贾文婷,丁周志. 降钙素原联合超敏C反应蛋白检测在新生儿细菌感染诊断中的价值[J]. 安徽医学,2018,39(4):478-480. doi: 10.3969/j.issn.1000-0399.2018.04.029 [20] 陈霆,燕旭东,涂惠英,等. PCT及CRP联合检测在新生儿感染性疾病诊断中的价值[J]. 检验医学与临床,2018,15(5):617-619,622. doi: 10.3969/j.issn.1672-9455.2018.05.013